Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Jul;63(7):2619–2624. doi: 10.1128/iai.63.7.2619-2624.1995

Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection.

A Cassone 1, M Boccanera 1, D Adriani 1, G Santoni 1, F De Bernardis 1
PMCID: PMC173351  PMID: 7790077

Abstract

Oophorectomized, estrogen-treated rats were susceptible to experimental vaginal infection by Candida albicans. After spontaneous clearing of the primary infection, the animals were highly resistant to a second vaginal challenge with the fungus. The vaginal fluid of Candida-resistant rats contained antibodies directed against mannan constituents and secretory aspartyl proteinase(s) of C. albicans and was capable of transferring a degree of anti-Candida protection to naive, nonimmunized rats. This passive protection was mediated by the immunoglobulin fraction of the vaginal fluid and was substantially abolished by preabsorption of the vaginal fluid with C. albicans, but not with Saccharomyces cerevisiae, cells. Vaginal anti-mannan antibodies were also produced by active immunization with heat-killed cells of C. albicans or with a mannan extract when administered via the vaginal route. The protection conferred was comparable to that resulting from clearing of the primary infection. In summary, the data suggest that acquired anticandidal protection in this vaginitis model is mediated at least in part by antibodies, among which those directed against the mannan antigen(s) might play a dominant role.

Full Text

The Full Text of this article is available as a PDF (212.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Calderone R. A., Braun P. C. Adherence and receptor relationships of Candida albicans. Microbiol Rev. 1991 Mar;55(1):1–20. doi: 10.1128/mr.55.1.1-20.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Casanova M., Martínez J. P., Chaffin W. L. Fab fragments from a monoclonal antibody against a germ tube mannoprotein block the yeast-to-mycelium transition in Candida albicans. Infect Immun. 1990 Nov;58(11):3810–3812. doi: 10.1128/iai.58.11.3810-3812.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cassone A. Cell wall of Candida albicans: its functions and its impact on the host. Curr Top Med Mycol. 1989;3:248–314. doi: 10.1007/978-1-4612-3624-5_10. [DOI] [PubMed] [Google Scholar]
  4. Cassone A., De Bernardis F., Mondello F., Ceddia T., Agatensi L. Evidence for a correlation between proteinase secretion and vulvovaginal candidosis. J Infect Dis. 1987 Nov;156(5):777–783. doi: 10.1093/infdis/156.5.777. [DOI] [PubMed] [Google Scholar]
  5. Cutler J. E. Putative virulence factors of Candida albicans. Annu Rev Microbiol. 1991;45:187–218. doi: 10.1146/annurev.mi.45.100191.001155. [DOI] [PubMed] [Google Scholar]
  6. De Bernardis F., Adriani D., Lorenzini R., Pontieri E., Carruba G., Cassone A. Filamentous growth and elevated vaginopathic potential of a nongerminative variant of Candida albicans expressing low virulence in systemic infection. Infect Immun. 1993 Apr;61(4):1500–1508. doi: 10.1128/iai.61.4.1500-1508.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. De Bernardis F., Agatensi L., Ross I. K., Emerson G. W., Lorenzini R., Sullivan P. A., Cassone A. Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis. J Infect Dis. 1990 Jun;161(6):1276–1283. doi: 10.1093/infdis/161.6.1276. [DOI] [PubMed] [Google Scholar]
  8. De Bernardis F., Lorenzini R., Verticchio R., Agatensi L., Cassone A. Isolation, acid proteinase secretion, and experimental pathogenicity of Candida parapsilosis from outpatients with vaginitis. J Clin Microbiol. 1989 Nov;27(11):2598–2603. doi: 10.1128/jcm.27.11.2598-2603.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. De Bernardis F., Molinari A., Boccanera M., Stringaro A., Robert R., Senet J. M., Arancia G., Cassone A. Modulation of cell surface-associated mannoprotein antigen expression in experimental candidal vaginitis. Infect Immun. 1994 Feb;62(2):509–519. doi: 10.1128/iai.62.2.509-519.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Domer J. E. Candida cell wall mannan: a polysaccharide with diverse immunologic properties. Crit Rev Microbiol. 1989;17(1):33–51. doi: 10.3109/10408418909105721. [DOI] [PubMed] [Google Scholar]
  11. Fidel P. L., Jr, Lynch M. E., Conaway D. H., Tait L., Sobel J. D. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity. Infect Immun. 1995 Feb;63(2):547–553. doi: 10.1128/iai.63.2.547-553.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fidel P. L., Jr, Lynch M. E., Sobel J. D. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis. Infect Immun. 1993 Oct;61(10):4202–4207. doi: 10.1128/iai.61.10.4202-4207.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fidel P. L., Jr, Lynch M. E., Sobel J. D. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect Immun. 1993 May;61(5):1990–1995. doi: 10.1128/iai.61.5.1990-1995.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fidel P. L., Jr, Lynch M. E., Sobel J. D. Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis. Infect Immun. 1994 Mar;62(3):1032–1038. doi: 10.1128/iai.62.3.1032-1038.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kanbe T., Cutler J. E. Evidence for adhesin activity in the acid-stable moiety of the phosphomannoprotein cell wall complex of Candida albicans. Infect Immun. 1994 May;62(5):1662–1668. doi: 10.1128/iai.62.5.1662-1668.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Polonelli L., De Bernardis F., Conti S., Boccanera M., Gerloni M., Morace G., Magliani W., Chezzi C., Cassone A. Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies. J Immunol. 1994 Mar 15;152(6):3175–3182. [PubMed] [Google Scholar]
  17. Ryley J. F., McGregor S. Quantification of vaginal Candida albicans infections in rodents. J Med Vet Mycol. 1986 Dec;24(6):455–460. [PubMed] [Google Scholar]
  18. Sobel J. D. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 1985 Aug 1;152(7 Pt 2):924–935. doi: 10.1016/s0002-9378(85)80003-x. [DOI] [PubMed] [Google Scholar]
  19. Sobel J. D., Muller G., Buckley H. R. Critical role of germ tube formation in the pathogenesis of candidal vaginitis. Infect Immun. 1984 Jun;44(3):576–580. doi: 10.1128/iai.44.3.576-580.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sobel J. D., Muller G., McCormick J. F. Experimental chronic vaginal candidosis in rats. Sabouraudia. 1985 Jun;23(3):199–206. doi: 10.1080/00362178585380301. [DOI] [PubMed] [Google Scholar]
  21. Sobel J. D. Pathogenesis of Candida vulvovaginitis. Curr Top Med Mycol. 1989;3:86–108. doi: 10.1007/978-1-4612-3624-5_5. [DOI] [PubMed] [Google Scholar]
  22. Torosantucci A., Palma C., Boccanera M., Ausiello C. M., Spagnoli G. C., Cassone A. Lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans. J Gen Microbiol. 1990 Nov;136(11):2155–2163. doi: 10.1099/00221287-136-11-2155. [DOI] [PubMed] [Google Scholar]
  23. Witkin S. S. Immunology of recurrent vaginitis. Am J Reprod Immunol Microbiol. 1987 Sep;15(1):34–37. doi: 10.1111/j.1600-0897.1987.tb00147.x. [DOI] [PubMed] [Google Scholar]
  24. Witkin S. S., Yu I. R., Ledger W. J. Inhibition of Candida albicans--induced lymphocyte proliferation by lymphocytes and sera from women with recurrent vaginitis. Am J Obstet Gynecol. 1983 Dec 1;147(7):809–811. doi: 10.1016/0002-9378(83)90044-3. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES